Please use this identifier to cite or link to this item:
|Title:||Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone||Authors:||Yong, E.L.
|Keywords:||Chronic low-dose FSH
Polycystic ovarian syndrome
Polycystic ovarian syndrome-like
|Issue Date:||1997||Citation:||Yong, E.L., Ng, S.C., Chan, C., Kumar, J., Teo, L.S., Ratnam, S. (1997). Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone. International Journal of Gynecology and Obstetrics 57 (3) : 305-311. ScholarBank@NUS Repository.||Abstract:||Objective: To determine whether patients with classical polycystic ovarian syndrome (PCOS) respond differently to low-dose FSH therapy in comparison with anovulatory patients (PCOS-like) where only some features of PCOS are present. Methods: Two groups of patients were studied. The PCOS group (25 patients, 51 cycles) and the PCOS-like group (38 patients, 57 cycles) were treated with the same protocol of purified FSH, commencing with an initial dosage of 75 IU/day and increasing by 37.5 IU/day after 14 days, where necessary. Estradiol levels and ultrasonographic evidence of follicular development were used for monitoring. Results: PCOS patients required more ampules of FSH, needed more days of gonadotropin stimulation, secreted higher levels of E2 and had increased numbers of intermediate follicles compared to the PCOS-like group. Conclusions: This study demonstrated significant differences between PCOS and other PCOS-like conditions when treated with low-dose FSH. Classification of the subvariants of PCOS may have therapeutic implications.||Source Title:||International Journal of Gynecology and Obstetrics||URI:||http://scholarbank.nus.edu.sg/handle/10635/37171||ISSN:||00207292|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 28, 2018
WEB OF SCIENCETM
checked on Jul 17, 2019
checked on Dec 2, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.